Breast Cancer
RSSArticles
-
Cytokeratin 20 in Noncolorectal Lymph Nodes
-
Clinical Briefs in Primary Care Supplement
-
Special Feature: Maintaining Board Certification
-
Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2
-
Clinical Staging and Chemoradiation for Early Stage Hodgkin’s Disease
-
Ascites, Neoadjuvant Chemotherapy, and Ovarian Cancer
-
XRT to Prevent Local Breast Cancer Recurrence: A Little More is Better
-
Pharmacology Watch: Warning Regarding Topical Anesthetics
In this issue: FDA warning on topical anesthetics; antipsychotics increase sudden cardiac death; the step up vs step down debate; treating pain, fatigue, mood, and sleep in fibromyalgia; FDA Actions. -
Special Feature: On the Origin of Ovarian Cancer Is It the Ovary?
One of the most common and poignant questions an ovarian cancer patient asks upon learning of her diagnosis is, "How did I get this? -
Hormone Therapy Improves Quality of Life in Older Women
The Women's Iinternational Study of Long Duration Oestrogen after the Menopause (WISDOM) trial was a randomized, controlled trial in the United Kingdom, Australia, and New Zealand, of 3721 women aged 50-69 treated with either combined 0.625 mg conjugated estrogens and 2.5/5.0 mg medroxyprogesterone, or placebo. The original plan was to randomize 22,300 women to the study that would last 10 years.